<HashMap><database>biostudies-literature</database><scores/><additional><submitter>van de Stadt LA</submitter><funding>Dutch Arthritis Society</funding><pagination>1350-1355</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9977113</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(3)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To investigate whether biomarkers are modulated by prednisolone treatment in patients with hand OA and whether they can predict response to prednisolone.&lt;h4>Methods&lt;/h4>Biomarkers reflecting tissue turnover and inflammation [aggrecanase-derived neoepitope of arggecan (ARGS), MMP-derived neoepitope of type I collagen (C1M), MMP-derived neoepitope of type III collagen (C3M), marker of true type V collagen formation (PROC5), MMP-derived neoepitope of CRP (CRPM), citrullinated vimentin fragment (VICM), high-sensitivity (hsCRP)] were measured in sera from 78 patients with painful inflammatory hand OA, who were randomized between prednisolone or placebo treatment. Association of baseline biomarker levels with disease characteristics [visual analogue scale (VAS) pain, synovial </pubmed_abstract><journal>Rheumatology (Oxford, England)</journal><pubmed_title>Serum biomarkers in prednisolone-treated hand osteoarthritis patients.</pubmed_title><pmcid>PMC9977113</pmcid><funding_grant_id>14-1-303</funding_grant_id><pubmed_authors>Kroon FPB</pubmed_authors><pubmed_authors>Bay-Jensen AC</pubmed_authors><pubmed_authors>Kloppenburg M</pubmed_authors><pubmed_authors>van de Stadt LA</pubmed_authors><pubmed_authors>Thudium CF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum biomarkers in prednisolone-treated hand osteoarthritis patients.</name><description>&lt;h4>Objectives&lt;/h4>To investigate whether biomarkers are modulated by prednisolone treatment in patients with hand OA and whether they can predict response to prednisolone.&lt;h4>Methods&lt;/h4>Biomarkers reflecting tissue turnover and inflammation [aggrecanase-derived neoepitope of arggecan (ARGS), MMP-derived neoepitope of type I collagen (C1M), MMP-derived neoepitope of type III collagen (C3M), marker of true type V collagen formation (PROC5), MMP-derived neoepitope of CRP (CRPM), citrullinated vimentin fragment (VICM), high-sensitivity (hsCRP)] were measured in sera from 78 patients with painful inflammatory hand OA, who were randomized between prednisolone or placebo treatment. Association of baseline biomarker levels with disease characteristics [visual analogue scale (VAS) pain, synovial </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T08:35:46.007Z</modification><creation>2025-04-04T08:35:46.007Z</creation></dates><accession>S-EPMC9977113</accession><cross_references><pubmed>35946535</pubmed><doi>10.1093/rheumatology/keac442</doi></cross_references></HashMap>